Brief: Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets To Strengthen Next-Gen Car Designs
02/04/2024 12:22
April 2 (Reuters) - Ginkgo Bioworks Holdings Inc
DNA.N :
* GINKGO BIOWORKS ACQUIRES MODULUS THERAPEUTICS' CELL
THERAPY
ASSETS TO STRENGTHEN NEXT-GEN CAR DESIGNS
Source text for Eikon: ID:nPn8z7hzCa
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary